POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETINGHELD ON JUNE 5, 2024

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.China Resources Medical Holdings Company Limited华润医疗控股有限公司 (Incorporated in the Cayman Islands with limited liability) (Stock Code: 1515) POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON JUNE 5 2024 Reference is made to the notice of extraordinary general meeting of China Resources Medical Holdings Company Limited (the “Company”) dated May 22 2024 (the “EGM Notice”) and the circular of the Company of even date (the “Circular”) in relation to among other things the continuing connected transactions regarding the CRH PMM Supplemental Framework Agreement and the Supplemental Cooperation Framework Agreement. Unless otherwise specified capitalized terms used herein shall have the same meanings as those defined in the Circular.The Board announces that all the proposed ordinary resolutions (the “Proposed OrdinaryResolutions”) as set out in the EGM Notice to the holders of the Company’s ordinary shares of HK$0.00025 each were passed by the Shareholders by way of poll at the EGM held on June 5 2024.As at the date of the EGM there were 1296676516 issued Shares. As stated in the Circular CRH is interested in 474319516 Shares (representing approximately 36.58% of the issued Shares): (1) 463681516 of such Shares are directly held by CRH (Medical) Limited. CRH (Medical) Limited is wholly owned by CR Healthcare. CR Healthcare is wholly owned by CRH (Healthcare) Limited. CRH (Healthcare) Limited is wholly owned by CRH; and (2) 10638000 of these Shares are directly held by Commotra Company Limited which is wholly owned by CRH. CRH is a controlling shareholder of the Company and has a material interest in both the CRH PMM Supplemental Framework Agreement and the Supplemental Cooperation Framework Agreement. As such CRH and its associates were required to abstain and did abstain from voting on the Proposed Ordinary Resolutions at the EGM.Computershare Hong Kong Trustees Limited being the trustee holding the unvested Shares awarded under the share award scheme of the Company (the “Scheme”) held 32384542 Shares. Consequently Computershare Hong Kong Trustees Limited was required to abstain from voting on matters that require Shareholders’ approval under the Listing Rules pursuant to Rule 17.05A of the Listing Rules and shall not exercise the voting rights in respect of the Shares held by it pursuant to the rules of the Scheme and hence it was required to abstain and did abstain from voting on the Proposed Ordinary Resolutions at the EGM. Therefore the total number of Shares entitling the Shareholders to attend and vote at the EGM in respect of the Proposed Ordinary Resolutions was 789972458 Shares. 1Save as disclosed above (i) there were no Shares entitling the Shareholders to attend and abstain from voting in favour of the Proposed Ordinary Resolutions at the EGM as set out in Rule 13.40 of the Listing Rules; (ii) there were no Shares requiring the Shareholders to abstain from voting on the Proposed Ordinary Resolutions at the EGM under the Listing Rules; and (iii) there were no restrictions on any Shareholders to cast votes on any of the Proposed Ordinary Resolutions at the EGM. There were no Shares voted on the Proposed Ordinary Resolutions at the EGM but excluded from calculating the poll results. No Shareholders have stated in the Circular their intention to vote against or to abstain from voting on any of the Proposed Ordinary Resolutions at the EGM.The branch share registrar of the Company in Hong Kong Computershare Hong Kong Investor Services Limited was appointed as the scrutineer for the vote-taking at the EGM.The poll results in respect of all the Proposed Ordinary Resolutions at the EGM are set out as follows: Number of Shares voted Total (approximately %) number Proposed Ordinary Resolutions For Against of Shares voted 1. “THAT: the execution of the pharmaceuticals medical 327618472 0 327618472devices and medical consumables supplemental (100%) (0%) framework agreement dated April 26 2024 (copy of which has been produced to the EGM marked “A” and signed by the chairman of the EGM for identification purpose) entered into between the Company and ChinaResources (Holdings) Company Limited (the “CRHPMM Supplemental Framework Agreement”) by any director(s) of the Company be and is hereby approved confirmed and ratified; any director(s) of the Company be and is hereby authorized to sign execute perfect and deliver all such documents and to affix the common seal of the Company on any such document as and when necessary and do all such deeds acts matters and things as he/she may in his/her discretion consider necessary or desirable for the purposes of or in connection with the implementation of the CRH PMM Supplemental Framework Agreement and the transactions contemplated thereunder; and the revised annual caps for the two years ending December 31 2025 for the transactions contempla ted under the CRH PMM Framework Agreement as agreed in the CRH PMM Supplemental Framework Agreement as set out in the circular of the Company dated May 22 2024 be and are herebyapproved.” 2Number of Shares voted Total (approximately %) number Proposed Ordinary Resolutions For Against of Shares voted 2. “THAT: the execution of the supplemental cooperation 327618472 0 327618472framework agreement dated April 26 2024 (copy of (100%) (0%) which has been produced to the EGM marked “B” and signed by the chairman of the EGM for identification purpose) entered into between the Company and China Resources Pharmaceutical Group Limited (the “Supplemental Cooperation Framework Agreement”) by any director(s) of the Company be and is hereby approved confirmed and ratified; any director(s) of the Company be and is hereby authorized to sign execute perfect and deliver all such documents and to affix the common seal of the Company on any such document as and when necessary and do all such deeds acts matters and things as he/she may in his/her discretion consider necessary or desirable for the purposes of or in connection with the implementation of the Supplemental Cooperation Framework Agreement and the transactions contemplated thereunder; and the revised annual cap for the year ending December 31 2024 and the proposed annual cap for the year ending December 31 2025 under the Supplemental Cooperation Framework Agreement as set out in the circular of the Company dated May 22 2024 be and are hereby approved.” Note: The number of Shares voted and approximate percentage of Shares voted are based on the total number of the issued Shares held by the Shareholders who voted at the EGM in person or by proxy.As more than 50% of the votes were cast by way of poll in favour of each of the Proposed Ordinary Resolutions all of the Proposed Ordinary Resolutions were duly passed at the EGM.Apart from Mr. YU Hai who was unable to attend due to other work arrangements the Directors namely Mr. SONG Qing Mr. SHAN Baojie Ms. YANG Min Ms. GE Lu Mr. WU Ting Yuk Anthony Mr. KWONG Kwok Kong Mr. FU Tingmei and Mr. ZHOU Peng attended the EGM either in person or by means of electronic facilities.By order of the Board China Resources Medical Holdings Company Limited SONG Qing Chairman Beijing June 5 2024 As at the date of this announcement the Board comprises Mr. SONG Qing Mr. YU Hai Mr. SHAN Baojie and Ms. YANG Min as executive Directors; Ms. GE Lu as non-executive Director; Mr. WU Ting Yuk Anthony Mr. KWONG Kwok Kong Mr. FU Tingmei and Mr. ZHOU Peng as independent non-executive Directors. 3